- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
Sterling Invests in Expansion of Integrated ADC Services
May 31st 2024
Sterling is strengthening its development and manufacturing services for ADCs with a dedicated GMP suite at its Wisconsin facility.
Lilly Raises Investment in Indiana Site to $9 Billion to Expand API Manufacturing
May 30th 2024
Lilly’s investment increase is intended to boost manufacturing capacity at its Lebanon, Ind., site for APIs used in the production of tirzepatide and other pipeline drug candidates.
Johnson & Johnson to Acquire Global Rights to Numab Therapeutics’ Bispecific Antibody for Atopic Dermatitis in $1.25 Billion Deal
May 30th 2024
Johnson & Johnson will gain NM26, a bispecific antibody targeting atopic dermatitis, via the acquisition of a wholly owned subsidiary of Numab Therapeutics.
AGC Biologics Partners with BioConnection to Offer Biopharma Drug Substance and Drug Product Development and Manufacturing
May 25th 2024
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
Biogen to Acquire HI-Bio in Deal Worth Potentially Up to $1.8 Billion
May 24th 2024
With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.
Merck KGaA Announces $600 Million Deal to Acquire Mirus Bio
May 24th 2024
With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.
How TekniPlex is Expanding to Support Innovative Solutions in Materials Science
May 17th 2024
TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO.
IMA Life North America Breaks Ground on New Facility in Tonawanda, NY
May 17th 2024
The new 80,000-square-foot facility will increase production of the company’s freeze-drying equipment.
New Cell Factory Box Launched by ProPharma and PBL for Automated CGT Manufacturing
May 7th 2024
ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.
SK pharmteco to Ensure Supply of Ferring Pharmaceuticals Gene Therapy
April 27th 2024
SK pharmteco, a CDMO, will manufacture, test, and release Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy from Ferring Pharmaceuticals for treating bladder cancer.